CN103263655A - Chinese medicine composition for treating gouty arthritis - Google Patents

Chinese medicine composition for treating gouty arthritis Download PDF

Info

Publication number
CN103263655A
CN103263655A CN2013102135066A CN201310213506A CN103263655A CN 103263655 A CN103263655 A CN 103263655A CN 2013102135066 A CN2013102135066 A CN 2013102135066A CN 201310213506 A CN201310213506 A CN 201310213506A CN 103263655 A CN103263655 A CN 103263655A
Authority
CN
China
Prior art keywords
parts
rhizoma
radix
chinese medicine
medicine composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2013102135066A
Other languages
Chinese (zh)
Inventor
石欣
Original Assignee
石欣
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 石欣 filed Critical 石欣
Priority to CN2013102135066A priority Critical patent/CN103263655A/en
Publication of CN103263655A publication Critical patent/CN103263655A/en
Pending legal-status Critical Current

Links

Abstract

The invention provides a Chinese medicine composition for treating gouty arthritis. The Chinese medicine composition is prepared from the following raw medicinal materials in parts by weight: 20 parts of radix clematidis, 10 parts of radix aconiti preparata, 9 parts of carthamus tinctorius, 20 parts of sargent gloryvine, 12 parts of edible tulip, 20 parts of coix seed, 20 parts of medicinal cyathula root, 30 parts of lysimachia christinae hance, 20 parts of yam rhizome, 30 parts of rhizoma smilacis glabrae, 20 parts of ash bark, 20 parts of grifola, 6 parts of long pepper, 20 parts of caulis sinomenii, 15 parts of the root of fangji, 20 parts of rhizoma alismatis, 20 parts of plantain herb, 15 parts of bark of himalayan coralbean, 9 parts of rhizoma sparganii, 15 parts of semen plantaginis, 10 parts of mountain spicy tree fruit, 9 parts of rhizoma pinelliae preparata, 10 parts of golden cypress, 12 parts of rhizoma corydalis, 12 parts of root of common peony, 15 parts of cortex acanthopanacis, 15 parts of rhizoma atractylodis, 12 parts of loranthus parasiticus, 6 parts of rheum officinale, 12 parts of the root bark of the peony tree, 12 parts of radix angelicae pubescentis, 25 parts of dried ginger, 15 parts of Chinese angelica and 20 parts of ramulus mori. The Chinese medicine composition is remarkable in treatment effect and high in clinical cure rate.

Description

A kind of Chinese medicine composition for the treatment of gouty arthritis
Technical field
The present invention relates to a kind of medicine for the treatment of gout, be specifically related to a kind of Chinese medicine composition of the treatment gouty arthritis that is prepared from by Chinese herbal medicine.
Background technology
In recent years, along with growth in the living standard, the change of dietary structure, the prevalence of hyperuricemia and gout day by day increases.Medicine commonly used such as colchicine, nonsteroidal antiinflammatory drug, glucocorticoid etc. are though pain relieving rapidly because toxic and side effects such as hepatorenal damage, GI irritation are bigger, used clinically and is subjected to certain limitation.Acute gouty arthritis is under the jurisdiction of the category of the traditional Chinese medical science " hot fraud ", " gout ", its onset because of interior by delicious food usually excessively, the wet part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels of stopping up, attacked due to people's flesh tendon by damp outward.Chinese traditional treatment is because of its treating both the principal and secondary aspects of a disease and the little favor that more and more is subjected to curing the patient of toxic and side effects, but in the existing medicine, acute gouty arthritis but rarely had medicine evident in efficacy.
Summary of the invention
In order to solve the problems of the technologies described above, the invention provides a kind of Chinese medicine composition for the treatment of gouty arthritis of determined curative effect.
The Chinese medicine composition for the treatment of acute gouty arthritis provided by the invention is prepared from by the crude drug of following weight proportion: Radix Clematidis 20, Radix Aconiti Preparata 10, Flos Carthami 9, Caulis Sargentodoxae 20, Pseudobulbus Cremastrae Seu Pleiones 12, Semen Coicis 20, Radix Cyathulae 20, Herba Lysimachiae 30 Rhizoma Dioscoreae Septemlobae 20, Rhizoma Smilacis Glabrae 30, Cortex Fraxini 20, Polyporus 20, Fructus Piperis Longi 6, Caulis Sinomenii 20, Radix Stephaniae Tetrandrae 15, Rhizoma Alismatis 20, Herba Plantaginis 20, Cortex erythrinae 15, rhizoma sparganic 9, Semen Plantaginis 15, cubeb 10, Rhizoma Pinelliae 9, Cortex Phellodendri 10, Rhizoma Corydalis 12, Radix Paeoniae Rubra 12, Cortex Acanthopancis 15, Rhizoma Atractylodis 15, Herba Taxilli 12, Radix Et Rhizoma Rhei 6, Cortex Moutan 12, Radix Angelicae Pubescentis 12,25 parts of Rhizoma Zingiberiss, Radix Angelicae Sinensis 15, Ramulus Mori 20.
Preparation method adopts conventional method water to carry, 1 dose of day clothes.
Clinical data
1 case
Observed 60 routine cases are examined from May, 2008~2013 my gate in year March and the patient of in-patient department.Be divided into treatment group, matched group at random.30 examples are organized in treatment, male's 24 examples wherein, women's 6 examples; 32~67 years old age, average 47.16 ± 9.76 years old; Disease time 4~74 hours.Matched group 30 examples, male's 25 examples wherein, women's 5 examples; 28 ~ 65 years old age, average 44.35 ± 8.63 years old; Disease time 5~72 hours.Two groups of cases are learned processing by statistics, and there was no significant difference (P〉0.05), have comparability.
2 Therapeutic Method
The treatment group: take medicine of the present invention, 1 dose of every day, divide 2 times oral.
Matched group: colchicine, first dose of 1.0mg, per 2 hours 1 time thereafter, each 0.5mg, total amount was no more than 3mg in 24 hours, obeyed till pain relief or gastrointestinal reaction occurs, added and use allopurinol, 0.1g at every turn, every day 3 times.More than two groups all give low purine diet, carry out therapeutic evaluation after treating for 1 week.
3 observation of curative effect
3.1 criterion of therapeutical effect:
Clinical recovery: the symptom complete obiteration, joint function recovery is normal, and the blood uric acid inspection is normal;
Produce effects: cardinal symptom disappears, and function of joint is recovered substantially, and the blood uric acid inspection is normal substantially;
Effectively: cardinal symptom disappears substantially, and main function of joint and blood uric acid inspection make moderate progress;
Invalid: improvement is not seen in symptom and blood uric acid inspection.
3.2 therapeutic outcome: see table 1 for details.As can be known, treatment group total effective rate is better than matched group (P<0.05) from table.
Group The example number Recovery from illness Produce effects Effectively Invalid Total effective rate
The treatment group 30 8 17 4 1 96.67%
Matched group 30 3 9 10 8 73.33%
Compare P<0.05 with matched group.
The specific embodiment
Be further introduced below in conjunction with the present invention of embodiment.
Embodiment 1
Get Radix Clematidis 20 by weight, Radix Aconiti Preparata 10, Flos Carthami 9, Caulis Sargentodoxae 20, Pseudobulbus Cremastrae Seu Pleiones 12, Semen Coicis 20, Radix Cyathulae 20, Herba Lysimachiae 30 Rhizoma Dioscoreae Septemlobae 20, Rhizoma Smilacis Glabrae 30, Cortex Fraxini 20, Polyporus 20, Fructus Piperis Longi 6, Caulis Sinomenii 20, Radix Stephaniae Tetrandrae 15, Rhizoma Alismatis 20, Herba Plantaginis 20, Cortex erythrinae 15, rhizoma sparganic 9, Semen Plantaginis 15, cubeb 10, Rhizoma Pinelliae 9, Cortex Phellodendri 10, Rhizoma Corydalis 12, Radix Paeoniae Rubra 12, Cortex Acanthopancis 15, Rhizoma Atractylodis 15, Herba Taxilli 12, Radix Et Rhizoma Rhei 6, Cortex Moutan 12, Radix Angelicae Pubescentis 12,25 parts of Rhizoma Zingiberiss, Radix Angelicae Sinensis 15, Ramulus Mori 20; The decocting that adds 10 times, 8 times amounts boils 2 times, and each two hours, collecting decoction, being concentrated into relative density is that 1.05-1.15 is standby.

Claims (1)

1. Chinese medicine composition for the treatment of gouty arthritis, it is characterized in that, be prepared from by the crude drug of following weight proportion: Radix Clematidis 20, Radix Aconiti Preparata 10, Flos Carthami 9, Caulis Sargentodoxae 20, Pseudobulbus Cremastrae Seu Pleiones 12, Semen Coicis 20, Radix Cyathulae 20, Herba Lysimachiae 30 Rhizoma Dioscoreae Septemlobae 20, Rhizoma Smilacis Glabrae 30, Cortex Fraxini 20, Polyporus 20, Fructus Piperis Longi 6, Caulis Sinomenii 20, Radix Stephaniae Tetrandrae 15, Rhizoma Alismatis 20, Herba Plantaginis 20, Cortex erythrinae 15, rhizoma sparganic 9, Semen Plantaginis 15, cubeb 10, Rhizoma Pinelliae 9, Cortex Phellodendri 10, Rhizoma Corydalis 12, Radix Paeoniae Rubra 12, Cortex Acanthopancis 15, Rhizoma Atractylodis 15, Herba Taxilli 12, Radix Et Rhizoma Rhei 6, Cortex Moutan 12, Radix Angelicae Pubescentis 12,25 parts of Rhizoma Zingiberiss, Radix Angelicae Sinensis 15, Ramulus Mori 20.
CN2013102135066A 2013-06-03 2013-06-03 Chinese medicine composition for treating gouty arthritis Pending CN103263655A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2013102135066A CN103263655A (en) 2013-06-03 2013-06-03 Chinese medicine composition for treating gouty arthritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2013102135066A CN103263655A (en) 2013-06-03 2013-06-03 Chinese medicine composition for treating gouty arthritis

Publications (1)

Publication Number Publication Date
CN103263655A true CN103263655A (en) 2013-08-28

Family

ID=49007348

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2013102135066A Pending CN103263655A (en) 2013-06-03 2013-06-03 Chinese medicine composition for treating gouty arthritis

Country Status (1)

Country Link
CN (1) CN103263655A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109420090A (en) * 2017-08-21 2019-03-05 王世豪 A kind of Chinese medicine composition and preparation method thereof for treating gout

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102188571A (en) * 2011-05-10 2011-09-21 王启凌 Medicament for treating gout
CN102872314A (en) * 2012-10-28 2013-01-16 牛健坤 Drug for treating gout and preparation method for drug

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102188571A (en) * 2011-05-10 2011-09-21 王启凌 Medicament for treating gout
CN102872314A (en) * 2012-10-28 2013-01-16 牛健坤 Drug for treating gout and preparation method for drug

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109420090A (en) * 2017-08-21 2019-03-05 王世豪 A kind of Chinese medicine composition and preparation method thereof for treating gout

Similar Documents

Publication Publication Date Title
CN103239654A (en) Medicine for treating acute gouty arthritis
CN101524494A (en) Drug for treating gout
CN103690741A (en) Pharmaceutical composition for treating gout and gouty arthritis
CN102727779B (en) Pharmaceutical composition for treating ovarian cysts and preparation method thereof
CN104173986A (en) Traditional Chinese medicine for treating heart failure
CN104189859A (en) Traditional Chinese medicine for treating lung cancer
CN104043077A (en) Traditional Chinese medicine composition for tonifying qi and nourishing blood
CN102114230A (en) Medicament for treating psoriasis
CN108186863A (en) A kind of Chinese medicine for treating psoriasis
CN103705689A (en) Drug composition for treating gout and gouty arthritis
CN105641419A (en) Traditional Chinese medicine composition for treating Yin deficiency type cough caused by lung cancer
CN103263655A (en) Chinese medicine composition for treating gouty arthritis
CN105343313A (en) Traditional Chinese medicinal composition for treating senile skin pruritus and preparation method of traditional Chinese medicinal composition
CN102671160B (en) Traditional Chinese medicine decoction for treating edema and preparation method of traditional Chinese medicine decoction
CN103055289B (en) Traditional Chinese medicine composition for curing malignant lymphoma and preparation method thereof
CN102228591A (en) Preparation method of oral medicinal preparation for regulating menstruation and stopping pains
CN100388931C (en) Medicine for treating pelvic inflammation and its preparing method
CN104758369B (en) A kind of Chinese medicine composition and its preparation method and application
CN104083469B (en) A kind of Chinese medicine being used for the treatment of Senile Functional Constipation
CN103656199B (en) A kind of Chinese medicine for the treatment of deficiency of kidney yin syndrome cough
CN105106674A (en) Traditional Chinese medicine composition for treating senile skin pruritus and preparation method of composition
CN102698129B (en) Traditional Chinese medicine composition for treating postoperative intestinal adhesion
CN104127787A (en) Traditional Chinese medicinal plaster for treating constipations
CN105497727A (en) Constipation treating traditional Chinese medicine composition
CN104758594A (en) Traditional Chinese medicine composition for treating kidney yin deficiency type of cough

Legal Events

Date Code Title Description
PB01 Publication
C06 Publication
SE01 Entry into force of request for substantive examination
C10 Entry into substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20130828

C02 Deemed withdrawal of patent application after publication (patent law 2001)